BioSpace News Archive

Cognoa develops AI-powered digital therapeutics and medicines that advance the standard of care in pediatric behavioral health and improve lifelong outcomes for children

Dr. Mayer is the current Managing Director and Chairman of the Board of Merck Life Science Israel

Thorofare, New Jersey, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company” or “we”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced the pricing of a public offering of 1,990,000 units. Each unit is comprised of one share of common stock (or common stock equivalent) and one preferred stock warrant to purchase one share of Series C Convertible Preferred Stock. The units are being offered at a public offering price of $4.00 per unit. H.

The notes will be senior unsecured obligations of Select and will be guaranteed by certain of Select’s subsidiaries.

Results of the studies were published in Wound Repair and Regeneration and International Wound Journal.

LifeStation, a leading provider of medical alert monitoring systems and connected health solutions for aging seniors and caregivers, has announced the launch of LifeStation Mobile LTE, the most advanced mobile medical alert device in the industry.

New Outpatient Center Will Bring Leading Musculoskeletal Care to the Community

Alpha Holdings, Inc., the largest stockholder of OncoSec Medical Incorporated, with an approximate 15.1% ownership stake, issued the following response to OncoSec’s most recent announcements.

Robert McBurney steps down as President and Chief Executive Officer and assumes the position of Chief Research Officer

The transaction is subject to customary closing conditions and expected to be finalized by mid-December.